FundingMachineFunding Atlas programme
CRI Clinical Innovator
Cancer Research Institute
JurisdictionUnited StatesFunding typeGrant
Documented facts
Key facts
- Funder
- Cancer Research Institute
- Jurisdiction
- United States
- Record type
- Opportunity
- Funding type
- Grant
- Amount
- 1,000,000
- Next deadline
- 1 December 2026
Published rule provenance
Eligibility information
- Country / jurisdiction
Rule not encoded
- Organisation type
Rule not encoded
- Company size
Rule not encoded
- Stage
Encoded condition recorded; read its source quotation.
Eligibility rule, quoted from the funder
The CRI Clinical Innovator funds innovative phase I/II or phase II clinical studies with a strong emphasis on:
Quoted source- Therapeutic area
Rule not encoded
- Amount sought
Rule not encoded
Further quoted conditions
Eligibility rule, quoted from the funder: area
The CRI Clinical Innovator supports pioneering immunotherapy clinical trials designed and led by academic researchers.Quoted source
Site note: This record is not advice or a funder decision.